Overview

A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Human Thrombin is as effective as Bovine Thrombin in stopping surgical bleeding within 10 minutes of application.
Phase:
Phase 3
Details
Lead Sponsor:
Ethicon, Inc.
Collaborator:
OMRIX Biopharmaceuticals
Treatments:
Thrombin